Neurovascular Product Surveillance Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedtronic Neurovascular Clinical Affairs
About this trial
Post market surveillance registry
Eligibility criteria
Qualifiers
Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements
Patient has, or is intended to receive or be treated with, an eligible Medtronic product
Patient is consented within the enrollment window of the therapy received, as applicable
Patient is at least 18 years of age at time of enrollment.
Disqualifiers
Patient who is, or is expected to be inaccessible for follow-up
Patient with exclusion criteria required by local law
Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
Trial design
Treatments tested in this trial
- Treatment for intracranial aneurysms
- Treatment for Acute Ischemic Stroke
Treatment groups
4,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Medtronic Neurovascular Clinical Affairs
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Collaborator
Source ClinicalTrials.gov